Valuation Merchavia Holdings and Investments Ltd
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.10 ILa | +0.05% |
|
+0.27% | -14.57% |
Company Valuation: Merchavia Holdings and Investments Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 55.5 | 57.32 | 27.02 | 15.87 | 10.45 | 45.26 |
| Change | - | 3.28% | -52.87% | -41.25% | -34.17% | 333.07% |
| Enterprise Value (EV) 1 | 46.44 | 49.89 | 22.77 | 13.68 | 9.068 | 45.66 |
| Change | - | 7.43% | -54.36% | -39.93% | -33.71% | 403.47% |
| P/E ratio | 17.6x | 9.97x | -7.9x | -0.98x | -1.43x | -4.27x |
| PBR | 1.49x | 1.2x | 0.62x | 0.55x | 0.45x | 2.94x |
| PEG | - | 0.2x | 0x | -0x | 0x | -0.2x |
| Capitalization / Revenue | 7.47x | 5.4x | 6.49x | 8.59x | 87.8x | 1,029x |
| EV / Revenue | 6.25x | 4.7x | 5.47x | 7.4x | 76.2x | 1,038x |
| EV / EBITDA | 10.4x | 6.97x | 15.5x | -65.4x | -3.81x | -29.7x |
| EV / EBIT | 10.4x | 6.98x | 15.6x | -61.9x | -3.8x | -29.6x |
| EV / FCF | 7.72x | 8.64x | 13.6x | 25.1x | -26.1x | -49x |
| FCF Yield | 13% | 11.6% | 7.33% | 3.98% | -3.84% | -2.04% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.2125 | 0.35 | -0.2083 | -0.96 | -0.41 | -0.5048 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 7.426 | 10.61 | 4.161 | 1.848 | 0.119 | 0.044 |
| EBITDA 1 | 4.466 | 7.155 | 1.469 | -0.209 | -2.379 | -1.535 |
| EBIT 1 | 4.46 | 7.147 | 1.461 | -0.221 | -2.387 | -1.542 |
| Net income 1 | 2.988 | 5.852 | -3.607 | -16.23 | -6.973 | -10.16 |
| Net Debt 1 | -9.059 | -7.43 | -4.248 | -2.196 | -1.382 | 0.399 |
| Reference price 2 | 3.750 | 3.490 | 1.645 | 0.945 | 0.587 | 2.155 |
| Nbr of stocks (in thousands) | 14,800 | 16,425 | 16,425 | 16,799 | 17,802 | 21,001 |
| Announcement Date | 3/31/21 | 3/30/22 | 3/29/23 | 3/31/24 | 3/31/25 | 3/31/26 |
1ILS in Million2ILS
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 13.34M | ||
| 29.29x | 5.17x | 16.01x | 1.11% | 43.39B | ||
| 47.3x | 4.79x | 31.64x | -.--% | 34.7B | ||
| -17.93x | 275.37x | -16.05x | -.--% | 30.15B | ||
| 21.76x | 2.53x | 10.94x | -.--% | 29.83B | ||
| 31.98x | 8.16x | 20.99x | 0.39% | 28.46B | ||
| -21.32x | 13.76x | -21.38x | -.--% | 12.51B | ||
| 20.79x | 1.84x | 8.08x | 1.29% | 12.29B | ||
| Average | 15.98x | 44.52x | 7.17x | 0.4% | 23.92B | |
| Weighted average by Cap. | 20.49x | 48.06x | 10.79x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MRHL Stock
- Valuation Merchavia Holdings and Investments Ltd
Select your edition
All financial news and data tailored to specific country editions
















